RAPT Therapeutics, Inc. — Director's Dealing 2021

Aug 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2021-08-04

Reporting Person: HO WILLIAM (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-04	Common Stock	M	347	$6.18	Acquired	65069	Direct
2021-08-04	Common Stock	M	347	$6.3	Acquired	65416	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-04	Option (right to buy)	$6.18	M	347	Disposed	2028-03-27	Common Stock (347)	Direct
2021-08-04	Option (right to buy)	$6.30	M	347	Disposed	2029-03-27	Common Stock (347)	Direct

Footnotes

F1: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.